A common single nucleotide polymorphism can exacerbate long-QT type 2 syndrome leading to sudden infant death

Eyal Nof1, Jonathan M Cordeiro, Guillermo J Pérez

  • 1Masonic Medical Research Laboratory, Utica, NY 13501, USA.

Insights

A common gene variant combined with a mutation caused sudden infant death by accentuating HERG channel dysfunction. This finding aids in identifying infants at risk for long-QT syndrome-mediated arrhythmias.

Area of Science:

  • Genetics
  • Cardiology
  • Molecular Biology

Background:

  • Sudden arrhythmic death in infants is a significant medical challenge.
  • Identifying infants at risk for sudden death is crucial.

Observation:

  • A family experienced two cases of sudden infant death.
  • The infants inherited a common polymorphism from the father and a stop codon mutation from the mother, both of whom were asymptomatic.
  • Genetic analysis revealed a heterozygous nonsense mutation (P926AfsX14) in KCNH2 in the mother and a heterozygous polymorphism (K897T) in KCNH2 in the father.

Findings:

  • The deceased infants and aborted fetus inherited both the K897T polymorphism and the P926AfsX14 mutation.
  • Electrophysiological studies showed that coexpression of K897T and P926AfsX14 resulted in a greater loss of HERG channel function than either variant alone.
  • The combined variants led to a significantly prolonged QTc interval (560 ms) and incessant ventricular tachycardia in the infant.

Implications:

  • A common KCNH2 polymorphism (K897T) can significantly worsen the loss of function in mildly defective HERG channels.
  • This interaction can lead to long-QT syndrome-mediated arrhythmias and sudden infant death.
  • The findings highlight the importance of genetic screening for identifying at-risk infants and families.
Abstract

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...